Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00063895
Status:
COMPLETED
Last Update Posted:
2013-01-09
First Post:
2003-07-08
Brief Title:
Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer Ovarian Cancer or Squamous Cell Carcinoma of the Head and Neck
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Recurrent Non-small Cell Lung Cancer |
| Recurrent Ovarian Epithelial Cancer |
| Recurrent Squamous Cell Carcinoma of the Hypopharynx |
| Recurrent Squamous Cell Carcinoma of the Larynx |
| Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity |
| Recurrent Squamous Cell Carcinoma of the Nasopharynx |
| Recurrent Squamous Cell Carcinoma of the Oropharynx |
| Stage III Squamous Cell Carcinoma of the Hypopharynx |
| Stage III Squamous Cell Carcinoma of the Larynx |
| Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity |
| Stage III Squamous Cell Carcinoma of the Nasopharynx |
| Stage III Squamous Cell Carcinoma of the Oropharynx |
| Stage IIIA Non-small Cell Lung Cancer |
| Stage IIIA Ovarian Epithelial Cancer |
| Stage IIIB Non-small Cell Lung Cancer |
| Stage IIIB Ovarian Epithelial Cancer |
| Stage IIIC Ovarian Epithelial Cancer |
| Stage IV Non-small Cell Lung Cancer |
| Stage IV Ovarian Epithelial Cancer |
| Stage IV Squamous Cell Carcinoma of the Hypopharynx |
| Stage IV Squamous Cell Carcinoma of the Nasopharynx |
| Stage IVA Squamous Cell Carcinoma of the Larynx |
| Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity |
| Stage IVA Squamous Cell Carcinoma of the Oropharynx |
| Stage IVB Squamous Cell Carcinoma of the Larynx |
| Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity |
| Stage IVB Squamous Cell Carcinoma of the Oropharynx |
| Stage IVC Squamous Cell Carcinoma of the Larynx |
| Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity |
| Stage IVC Squamous Cell Carcinoma of the Oropharynx |
Keywords: